Interview with Dr James Garner, CEO of Kazia Therapeutics
-
Regulatory November 23, 2023Nomination Committee appointed for the 2024 Annual General Meeting in Vivesto
-
Regulatory November 23, 2023Vivesto and Elevar sign agreement ending Apealea® partnership
-
Regulatory November 16, 2023Interim report for the period January 1, 2023 – September 30, 2023
Vivesto published its Q3 report for 2023 on November 16, 2023, at 08.00 am CET.